Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) EPS (Weighted Average and Diluted): 2022-2024

Historic EPS (Weighted Average and Diluted) for Neurogene (NGNE) over the last 3 years, with Dec 2024 value amounting to -$4.28.

  • Neurogene's EPS (Weighted Average and Diluted) rose 16.81% to -$0.99 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.11, marking a year-over-year decrease of 1074.29%. This contributed to the annual value of -$4.28 for FY2024, which is 62.15% up from last year.
  • As of FY2024, Neurogene's EPS (Weighted Average and Diluted) stood at -$4.28, which was up 62.15% from -$11.31 recorded in FY2023.
  • In the past 5 years, Neurogene's EPS (Weighted Average and Diluted) registered a high of -$4.28 during FY2024, and its lowest value of -$139.88 during FY2022.
  • In the last 3 years, Neurogene's EPS (Weighted Average and Diluted) had a median value of -$11.31 in 2023 and averaged -$51.82.
  • Data for Neurogene's EPS (Weighted Average and Diluted) shows a peak YoY surged of 91.92% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Neurogene's EPS (Weighted Average and Diluted) stood at -$139.88 in 2022, then soared by 91.92% to -$11.31 in 2023, then soared by 62.15% to -$4.28 in 2024.